Skip to content

NCEL.CH

NewCelX Ltd.

Healthcare · Biotechnology · CH

Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue
Cost of Revenue22.6K3.3K11.4K11.4K
Gross Profit(22.6K)(3.3K)(11.4K)(11.4K)
Operating Expenses
R&D Expense1.9M1.1M422.1K5.9M9.0M
SG&A Expense5.3M1.3M3.2M5.9M6.5M
General & Admin Expense3.6M1.3M3.2M5.9M6.5K
Selling & Marketing Expense6.5M
Other Expenses3.0M743.8K
Total Operating Expenses10.3M2.5M4.4M11.8M15.5M
Cost and Expenses10.3M2.5M4.4M11.8M15.5M
Operating Income (EBIT)(11.0M)(2.5M)(4.4M)(11.8M)(15.5M)
Non-Operating
Interest Income35.0K369.0K100.87
Interest Expense5.8M6.0M150.0K145.2K100.9K
Net Interest Income(5.8M)(5.6M)(150.0K)(145.2K)(100.8K)
Other Non-Op Income/Expense10.4M(5.8M)2.4M(365.0K)(1.0M)
Non-Operating Income (excl Interest)(3.4M)(182.0K)(743.8K)778.0K912.4K
EBT (Pre-Tax Income)(662.7K)(8.3M)(2.0M)(12.2M)(16.5M)
Income Tax Expense57.4K
Bottom Line
Net Income(720.1K)(8.3M)(2.0M)(12.2M)(16.5M)
Earnings from Cont. Ops(720.1K)(8.3M)(2.0M)(12.2M)(16.5M)
Earnings from Discont. Ops
Bottom Line Net Income(7.5M)(8.3M)(4.1M)(12.2M)(16.5M)
Per Share
Basic EPS($36.47)($2.16)($26.30)($3.20)($8.40)
Diluted EPS($20.07)($2.16)($26.30)($3.20)($8.40)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding5.9M3.8M753003.8M2.0M
Diluted Shares Outstanding5.9M3.8M1543283.8M2.0M
Profitability Metrics
EBITDA(7.6M)(2.2M)(3.6M)(11.8M)(15.5M)
D&A48.7K55.0K3.3K11.4K11.4K
EBIT(7.7M)(2.3M)(3.6M)(11.8M)(15.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026